Navigation Links
Avantis Medical Systems, Inc. Announces Key Leadership Appointments
Date:8/25/2008

Medical Device Industry Experts Dodson and Tannenbaum Join as Chief

Executive Officer, Chief Financial Officer

SUNNYVALE, Calif., Aug. 25 /PRNewswire/ -- Avantis Medical Systems, Inc. announced today that it has appointed medical device industry experts Scott Dodson as President and Chief Executive Officer (CEO), and Larry Tannenbaum as Senior Vice President and Chief Financial Officer (CFO). Both executives will assume key roles with the Avantis management team.

"We are pleased to announce this new executive leadership team for Avantis," said Fred Seddiqui, founder and chairman of Avantis. "Scott was selected for his proven expertise in growing emerging companies and bringing new products to market. He will be instrumental in all factors of our commercialization, through research, manufacturing, and distribution. Larry brings extensive experience in managing growing companies and funding expansions."

Mr. Dodson is an accomplished medical device executive with a 20 year career of increasing responsibility, leading large global teams for world class companies. From 1992 - 2006, Dodson was with Boston Scientific in its Urology, Endoscopy and International Business units, also serving from 2004 - 2006 as Vice President of Global Marketing in the company's Endoscopy business unit. From 2006 - 2008, Dodson was President of the Orthopedic business for Orthofix, Inc., where he managed a large, cross-functional global team. Dodson earned his bachelor's degree in management from Indiana University, and has completed executive programs at Columbia University, Babson College, and the American Management Association.

"Avantis offers physicians a superior visualization system that will lead to early cancer detection, reduced miss rates and disease prevention," said Dodson. "I am honored to be joining at such an exciting time in the company's history."

Dodson discussed Tannenbaum's hire as Chief Financial Officer and Senior Vice President. "Larry brings an impressive record in medical device start-ups and has been instrumental in positioning a number of companies for acquisition and/or an initial public offering. He has been directly involved in developing, acquiring, and/or selling six companies, raising over $200 million and negotiating transactions up to $400 million."

Mr. Tannenbaum's career in finance spans over 30 years. Most recently he served in executive positions at Iridex as Senior Vice President and Chief Business Officer, as well as Chief Financial Officer. Prior to Iridex, Tannenbaum also worked in senior management positions for LJL Biosystems, Arthrocare diabetes start-up Metrika (now Bayer Diagnostics), drug manufacturer Sinogen, and Target Therapeutics (now Boston Scientific). He has also served as a lecturer at the Innovation Program for Stanford University for the past six years. He graduated summa cum laude from Arizona State University and earned his MBA in finance from the University of Utah.

"In Avantis, I see a company poised to leverage its market position to achieve commercial success, and I am proud to be part of the team planning for the company's future success," said Tannenbaum.

About Avantis

Avantis Medical Systems, Inc. is a visualization technology company focused on delivering cost effective solutions for the improved detection and prevention of cancers of the gastrointestinal (GI) tract.

The seasoned Avantis team is developing solutions for the limitations associated with today's technologies that are used to screen, assess and treat cancer throughout the alimentary tract and the body. Avantis has an extensive portfolio of patents covering innovative devices based on the convergent technologies of micro-chips, enhanced video processing and catheter based delivery systems. For more information, visit http://www.avantismedical.com.


'/>"/>
SOURCE Avantis Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... The Conference Forum has announced that the ... will take place on February 1-3, 2017 at the Roosevelt Hotel in New York ... program provides a unique 360-degree approach, which addresses the most up-to-date information regarding business ...
(Date:12/2/2016)... ... 01, 2016 , ... Orthogonal, a Chicago-based medical device software ... II 510(k) clearance for their flagship medical device, SimplECG. , With this FDA ... that rely on cloth-based nanosensors. While other companies have attempted to focus on ...
(Date:12/2/2016)... ... 2016 , ... Robots will storm the Prudential Center in Boston, MA during ... which is held on the United Nations International Day of Persons with Disabilities, will ... workplace. Suitable Technologies is partnering with NTI to showcase how technology can help individuals ...
(Date:12/2/2016)... , December 2, 2016 The immunohistochemistry ... growing at a CAGR of 7.3% during the forecast period of ... and diagnostic laboratories segment accounted for the largest share of immunohistochemistry ... ... on global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):